Mynaric AG
Case Overview
10 Days Left to Seek Lead Plaintiff
Lead Plaintiff Deadline: | Lead Plaintiff Deadline: 12/30/2024 |
Status: | Status: Investigating |
Company Name: | Company Name: Mynaric AG |
Court: | Court: Eastern District of New York |
Case Number: | Case Number: 1:24cv07602 |
Class Period: | Class Period: 06/20/2024 - 10/07/2024 |
Ticker: | Ticker: MYNA |
Related Attorneys: | Lead Attorneys: Thomas W. Elrod |
Related Practices: | Related Practices: Securities |
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf of those who acquired Mynaric AG (“Mynaric” or the “Company”) (NASDAQ: MYNA) securities during the period of June 20, 2024 to October 7, 2024, inclusive (“the Class Period”). Investors have until December 30, 2024, to apply to the Court to be appointed as lead plaintiff in the lawsuit.
On August 20, 2024, Mynaric issued a press release providing an update to its full-year 2024 guidance, advising that “the company now expects full-year 2024 IFRS-15 revenue to range between EUR 16.0 million to EUR 24.0 million compared to previous guidance of a range between EUR 50.0 million to EUR 70.0 million”, citing “production delays of CONDOR Mk3 caused by lower than expected production yields and component supplier shortages of key components”; and that “the company now expects full-year 2024 operating loss to range between a loss of EUR 55.0 million to EUR 50.0 million compared to previous guidance of a range between a loss of EUR 40.0 million to EUR 30.0 million”, citing “the lower than expected revenue and higher than expected production costs due to lower yields.” In a separate press release, Mynaric “announce[d] the voluntary departure of CFO Stefan Berndt von-Bülow for personal reasons, effective last week.” On this news, the price of Mynaric shares declined by $2.32 per share, or approximately 55.9%, from $4.15 per share on August 19, 2024 to close at $1.83 per share on August 20, 2024.
The lawsuit alleges that Mynaric made materially false and misleading statements regarding: (i) lower-than-expected production and supplier shortages of key components that were causing delays for its CONDOR Mk3 product; (ii) the likelihood that the foregoing issues would have a material negative impact on the Company's revenue growth and cause the Company to incur an operating loss; and (iii) the unlikelihood that Mynaric was going to meet its previously issued financial guidance for FY 2024.
On August 20, 2024, Mynaric issued a press release providing an update to its full-year 2024 guidance, advising that “the company now expects full-year 2024 IFRS-15 revenue to range between EUR 16.0 million to EUR 24.0 million compared to previous guidance of a range between EUR 50.0 million to EUR 70.0 million”, citing “production delays of CONDOR Mk3 caused by lower than expected production yields and component supplier shortages of key components”; and that “the company now expects full-year 2024 operating loss to range between a loss of EUR 55.0 million to EUR 50.0 million compared to previous guidance of a range between a loss of EUR 40.0 million to EUR 30.0 million”, citing “the lower than expected revenue and higher than expected production costs due to lower yields.” In a separate press release, Mynaric “announce[d] the voluntary departure of CFO Stefan Berndt von-Bülow for personal reasons, effective last week.” On this news, the price of Mynaric shares declined by $2.32 per share, or approximately 55.9%, from $4.15 per share on August 19, 2024 to close at $1.83 per share on August 20, 2024.
The lawsuit alleges that Mynaric made materially false and misleading statements regarding: (i) lower-than-expected production and supplier shortages of key components that were causing delays for its CONDOR Mk3 product; (ii) the likelihood that the foregoing issues would have a material negative impact on the Company's revenue growth and cause the Company to incur an operating loss; and (iii) the unlikelihood that Mynaric was going to meet its previously issued financial guidance for FY 2024.